---
figid: PMC9470892__ACEL-21-e13686-g002
pmcid: PMC9470892
image_filename: ACEL-21-e13686-g002.jpg
figure_link: /pmc/articles/PMC9470892/figure/acel13686-fig-0003/
number: FIGURE 3
figure_title: ''
caption: CaM/CaMKII and Nrf2/HO‐1/NQO1 signaling pathways were attenuated after YWHAE
  knockdown. (a) Changes in 14‐3‐3ε, t‐Nrf2, n‐Nrf2, HO‐1, NQO1, CaM, p‐CaMKII, CaMKII,
  p16INK4a, and p21 expression in hAMSCs upon different treatments. (b–i) Relative
  expression levels of 14‐3‐3ε, n‐Nrf2, t‐Nrf2, CaM, CaMKII, p‐CaMKII, HO‐1, NQO1,
  p16INK4a, and p21. N = 3. N‐Nrf2, nuclear Nrf2; t‐Nrf2, total Nrf2; p‐CaMKII, phosphorylated
  CaMKII; control, control group; H2O2, senescent group; GA‐D, GA‐D treatment group;
  mock‐vehicle, GA‐D treatment group plus empty carrier; h‐14‐3‐3ε, GA‐D treatment
  group plus YWHAE overexpression; sh‐14‐3‐3ε, GA‐D treatment group plus YWHAE knockdown;
  , mean ± standard deviation. *p < 0.05, **p < 0.01. CaM, calmodulin; CaMKII, CaM‐dependent
  protein kinase II; GA‐D, ganoderic acid D; H2O2, hydrogen peroxide; hAMSC, human
  amniotic mesenchymal stem cell; Nrf2, nuclear erythroid 2‐related factor 2.
article_title: Ganoderic acid D prevents oxidative stress‐induced senescence by targeting
  14‐3‐3ε to activate CaM/CaMKII/NRF2 signaling pathway in mesenchymal stem cells.
citation: Huan Yuan, et al. Aging Cell. 2022 Sep;21(9):e13686.
year: '2022'

doi: 10.1111/acel.13686
journal_title: Aging Cell
journal_nlm_ta: Aging Cell
publisher_name: John Wiley and Sons Inc.

keywords:
- 14‐3‐3ε
- aging mouse model
- anti‐aging
- bone‐marrow mesenchymal stem cells
- CaM/CaMKII/Nrf2 signaling
- ganoderic acid D
- human amniotic mesenchymal stem cells

---
